InspireMD Inc (NSPR) Q3 2025 Earnings Call Highlights: Robust Revenue Growth Amid Rising Expenses

InspireMD Inc (NSPR) reports a 39% revenue increase driven by the US launch of CGuard Prime, despite a widened net loss and increased operating expenses.

Arteris signals 24% ACV plus royalties growth and raises 2025 revenue target amid AI-driven demand

Q3 2025 Management View CEO Karel Janac reported "record annual contract value plus royalties of $74.9 million, resulting in ...